Morinaga D, Furuta M, Morita S, Miyauchi E, et al. A Phase 2 Study of Osimertinib in Combination With Platinum-Pemetrexed in Patients With Uncommon Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer (NEJ067/OPAL2). Clin Lung Cancer 2025 Aug 26:S1525-7304(25)00219.
PMID: 40973606